RRML - High frequency of BRCA recurrent mutations in a consecutive series of unselected ovarian cancer patients
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- September 2020 -
 
Romanian Review of Laboratory ... 21
Metabolomic biomarkers of poly... 13
Variability of ex-vivo stimula... 8
The association of anthropomet... 8
Role of fecal calprotectin as ... 6
The predictive role of platele... 6
Antibacterial and antitumor ac... 6
FLT-3 ITD Positive Acute Basop... 5
Implications of visfatin genet... 5
Characterization of antibiotic... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 28(3)/2020 DOI:10.2478/rrlm-2020-0026
XML
TXT

Research article

High frequency of BRCA recurrent mutations in a consecutive series of unselected ovarian cancer patients

Andrei Chicos, Lucian Negura, Rares Braescu, Aliona Morariu, Anca Negura, Andreea Chicos, Cristian Lupascu

Correspondence should be addressed to: Anca Negura

Abstract:

Hereditary predisposition to breast and ovarian cancer (HBOC) is diagnosed by molecular analysis of deleterious mutations in BRCA genes, allowing oncogenetic follow-up of patients and of their families. BRCA testing addresses only to HBOC families, using restrictive inclusion criteria based on familial history of cancer and age at diagnosis. Sporadic ovarian cancer has high incidence and mortality in Romania, with low median age of diagnosis and possibly a higher magnitude of hereditary contribution comparing to othe populations. However, sporadic ovarian cancers do not qualify for BRCA testing according to inclusion criteria, and a complete BRCA screening of all cancers is neither feasible nor recommended. Despite the large diversity of BRCA mutations worldwide, some recurrent mutations have higher frequencies in diverse populations. Precisely screening for recurrent mutations in a target population allows to rapidly identifying mutation carriers without sequencing the entire BRCA genes. In Romanian population and neighboring countries, several recurrent mutations have already been described. In a consecutive series of 50 sporadic ovarian cancer patients, not qualifying for BRCA complete testing, we screened for 9 most common BRCA mutations, by multiplex-PCR, RFLP and targeted Sanger sequencing. Our results revealed 6 different BRCA mutations in 8 unrelated patients, with a frequency of 16%, much higher than expected. We further recommend screening for the identified mutations in larger series of cancer patients. The results are highly beneficial to cancer patients, healthy relatives, and overall, considering prevention in cancer a priority, to public health system and future of oncogenetics in Romania

Keywords: ovarian cancer, hereditary predisposition, BRCA genes, recurrent mutations

Received: 23.3.2020
Accepted: 6.5.2020
Published: 22.5.2020

 
  PDF Download full text PDF
(1651 KB)
     
 
How to cite
Chicos A, Negura L, Braescu R, Morariu A, Negura A, Chicos A, et al. High frequency of BRCA recurrent mutations in a consecutive series of unselected ovarian cancer patients. Rev Romana Med Lab. 2020;28(3):257-66. DOI:10.2478/rrlm-2020-0026